Adult stem cells/glaucoma drug combo promotes diabetic wound healing in mice

A new study released today in Stem Cells Translational Medicine shows promise of a major breakthrough in healing chronic foot ulcers resulting from diabetes. The study, by researchers at the University of California, Davis, is the first to demonstrate how a bioengineered scaffold made up of human mesenchymal stem cells (MSCs) combined with timolol—a drug commonly used to treat glaucoma—improved […]

Read more

COVID-19: drug reduces heavy over the course of 80 percent natural healing natural healing portal

Coronavirus: drug gives hope New research from the UK to make hope in the fight against the Coronavirus SARS-CoV-2 and the pathogen-triggered disease COVID-19. A drug to be Inhaled can gradients, therefore, the risk for severe disease, as well as the risk of death dramatically reduce. In a recent communication, the University of Southampton and the drug development company Synairgen […]

Read more

Experimental drug reduces replication of zika virus and prevents microcephaly in mice

An international group of researchers have discovered that inhibiting AHR (aryl hydrocarbon receptor)—a protein with roles in regulating immunity, stem cell maintenance and cellular differentiation—enables the immune system to combat replication of zika virus in the organism far more effectively. In experiments performed at the University of São Paulo’s Biomedical Sciences Institute (ICB-USP) in Brazil, the antiviral therapy proved capable […]

Read more

First drug proves able to improve survival from COVID-19, researchers say – The Denver Post

Researchers in England say they have the first evidence that a drug can improve COVID-19 survival: A cheap, widely available steroid called dexamethasone reduced deaths by up to one third in severely ill hospitalized patients. Results were announced Tuesday and researchers said they would publish them soon. The study is a large, strict test that randomly assigned 2,104 patients to […]

Read more

Novel targeted drug induced positive response for VHL-associated kidney cancer

In an international trial led by researchers at The University of Texas MD Anderson Cancer Center, treatment with MK-6482, the small molecule inhibitor of hypoxia-inducible factor (HIF)-2a was well tolerated and resulted in clinical responses for patients with von Hippel-Lindau disease (VHL)-associated renal cell carcinoma (RCC). The results of the Phase II trial were shared today in an oral presentation […]

Read more

Sedative drug in combination with opioids may be especially dangerous

Results from a study of adults with kidney failure suggest that taking both short-acting benzodiazepines and opioids may put patients at an especially high risk of dying prematurely. The findings appear in an upcoming issue of CJASN. Increasing use of opioids in recent years has led to rising numbers of deaths and hospitalizations due to overdoses. In light of this […]

Read more

FDA may approve emergency use of Ebola drug remdesivir TODAY

BREAKING NEWS: FDA may approve emergency use authorization of Ebola drug remdesivir TODAY after Dr Fauci called early results of one study ‘very optimistic’ The FDA may announce its decision allowing emergency use authorization of an antiviral remdesivir for coronavirus patients as early as Wednesday It comes as Gilead Sciences treated 397 severely ill patients and found  more than half of […]

Read more

U.S. states build stockpiles of malaria drug touted by Trump

State and local governments across the United States have obtained more than 30 million doses of a malaria drug touted by President Trump to treat patients with the new coronavirus, despite warnings from doctors that more research is needed. At least 22 states and Washington, D.C. secured shipments of the drug, hydroxychloroquine, according to information compiled from state and federal […]

Read more

‘In a crisis like this, an antiviral drug could buy us some time’

Francesco Stellacci, a professor in EPFL’s School of Engineering, discusses his research in the field of nanomedicine and how it could help us get past the coronavirus crisis. As the COVID-19 outbreak rages on, researchers are in a race against the clock to find some way to combat the coronavirus. Francesco Stellacci, the professor who heads the Supramolecular Nano-Materials and […]

Read more

Chronic migraine sufferers to get first new drug in 20 years

Chronic migraine sufferers are given fresh hope of getting rid of their crippling headaches with first new drug in 20 years New drug self-injected at home will benefit 10,000 people suffering migraines Fremanezumab was developed by UK scientists over three decades In trials the drug has reduced the frequency, severity and duration of migraines Lead researcher called the introduction of […]

Read more
1 2 3 6